.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Merck
Dow
Fuji
Chubb
Medtronic
Chinese Patent Office
UBS
US Army
Harvard Business School

Generated: September 19, 2017

DrugPatentWatch Database Preview

8-MOP Drug Profile

« Back to Dashboard

Which patents cover 8-mop, and what generic 8-mop alternatives are available?

8-mop is a drug marketed by Valeant Pharm Intl and is included in one NDA.

The generic ingredient in 8-MOP is methoxsalen. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.

Summary for Tradename: 8-MOP

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list82
Clinical Trials: see list9
Patent Applications: see list3,180
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:8-MOP at DailyMed

Pharmacology for Tradename: 8-MOP

Ingredient-typePsoralens
Drug ClassPhotoactivated Radical Generator
Psoralen
Mechanism of ActionPhotoabsorption
Physiological EffectPhotosensitizing Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharm Intl
8-MOP
methoxsalen
CAPSULE;ORAL009048-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Argus Health
Daiichi Sankyo
Mallinckrodt
Accenture
Farmers Insurance
US Department of Justice
McKinsey
Cantor Fitzgerald
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot